Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study

Scand J Trauma Resusc Emerg Med. 2023 Oct 25;31(1):61. doi: 10.1186/s13049-023-01134-5.

Abstract

Background: Accidental hypothermia, recognized by core temperature below 35 °C, is a lethal condition with a mortality rate up to 25%. Hypothermia-induced cardiac dysfunction causing increased total peripheral resistance and reduced cardiac output contributes to the high mortality rate in this patient group. Recent studies, in vivo and in vitro, have suggested levosimendan, milrinone and isoprenaline as inotropic treatment strategies in this patient group. However, these drugs may pose increased risk of ventricular arrhythmias during hypothermia. Our aim was therefore to describe the effects of levosimendan, milrinone and isoprenaline on the action potential in human cardiomyocytes during hypothermia.

Methods: Using an experimental in vitro-design, levosimendan, milrinone and isoprenaline were incubated with iCell2 hiPSC-derived cardiomyocytes and cellular action potential waveforms and contraction were recorded from monolayers of cultured cells. Experiments were conducted at temperatures from 37 °C down to 26 °C. One-way repeated measures ANOVA was performed to evaluate differences from baseline recordings and one-way ANOVA was performed to evaluate differences between drugs, untreated control and between drug concentrations at the specific temperatures.

Results: Milrinone and isoprenaline both significantly increases action potential triangulation during hypothermia, and thereby the risk of ventricular arrhythmias. Levosimendan, however, does not increase triangulation and the contractile properties also remain preserved during hypothermia down to 26 °C.

Conclusions: Levosimendan remains a promising candidate drug for inotropic treatment of hypothermic patients as it possesses ability to treat hypothermia-induced cardiac dysfunction and no increased risk of ventricular arrhythmias is detected. Milrinone and isoprenaline, on the other hand, appears more dangerous in the hypothermic setting.

Keywords: Accidental hypothermia; Cardiomyocytes; Contractility; Electrophysiology; Hypothermia; Isoprenaline; Levosimendan; Milrinone.

MeSH terms

  • Cardiotonic Agents / pharmacology
  • Cardiotonic Agents / therapeutic use
  • Heart Diseases* / drug therapy
  • Humans
  • Hydrazones / pharmacology
  • Hydrazones / therapeutic use
  • Hypothermia* / chemically induced
  • Isoproterenol / pharmacology
  • Milrinone / pharmacology
  • Milrinone / therapeutic use
  • Myocytes, Cardiac
  • Pyridazines* / pharmacology
  • Pyridazines* / therapeutic use
  • Simendan

Substances

  • Simendan
  • Milrinone
  • Cardiotonic Agents
  • Isoproterenol
  • Hydrazones
  • Pyridazines

Grants and funding